By
MikeH on
February 5, 2013
Many in the Diabetes Community are anxiously awaiting the release of the smaller and sleeker 2nd generation OmniPod, but already we know what a third generation won’t have:
A Pod that’s integrated with a Dexcom CGM sensor.
Yep, it’s true: the two companies say they have abandoned the integration deal they had in place since 2008.
Two executives at Massachusetts-based Insulet Corp., makers of the OmniPod, say they’re no longer working with California-based Dexcom on…
Read more »
By
MikeH on
January 8, 2013
In the world of diabetes devices, company execs, PR pros, sales reps and even doctors are often vague about when new products will hit the market and be available for us people with diabetes. They tout new tools “coming soon” without any specificity as to when a product might actually be available. And on message boards frequented by patients, rumors can fly.
After an exciting year of new diabetes product approvals in 2012, we wanted…
Read more »
By
WilD on
August 22, 2012
It looks like a duck. It quacks like a … Oh. Wait a minute. It doesn’t quack at all. So why is Abbott Diabetes calling it a duck? (That’s a metaphorical question, just so you know.)
The metaphoric duck we’re talking about lives over in Europe and is quacking along just fine. Its real name is the Abbott Freestyle InsuLinx glucose meter, and it was introduced in Europe in May 2011 and Canada this May,…
Read more »
By
AmyT on
March 16, 2011
“Mom, you have a new beep!”
— my 13-year-old, apparently discovering my new CGM
I am back on the Dexcom (!), and feeling the truth behind the saying, ‘third time’s a charm.’ I all but swore off continuous glucose monitoring systems more than a year ago after stints trying all three on the market (Dexcom, Medtronic Guardian, Abbott Navigator), in which the discomfort and inconvenience seemed to clearly outweigh the benefits.
But as you…
Read more »
By
AmyT on
March 10, 2010
Following my series of interviews with Kris Freeman, I got a note from competitive cyclist Phil Southerland, founder of Team Type 1. He wanted to let me know how well his group of athletes with type 1 diabetes have been performing so far this year.
Phil was concerned that the mainstream media coverage of Freeman’s challenges may have stirred up “a lot of negativity about diabetes.” So he asked me if he could submit a…
Read more »
